These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7817584)

  • 1. [Fibrates in the treatment of hyperlipidemia].
    Kłosiewicz-Latoszek L; Szostak WB
    Wiad Lek; 1993 Nov; 46(21-22):872-6. PubMed ID: 7817584
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of dyslipidemias and its benefits].
    Taskinen MR
    Duodecim; 1999; 115(10):1138-44. PubMed ID: 11877853
    [No Abstract]   [Full Text] [Related]  

  • 3. [What other effects do statins have except their effect on lipids?].
    Tikkanen MJ
    Duodecim; 1998; 114(13):1299-301. PubMed ID: 11552256
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of hyperlipidemia].
    Müller G
    Dtsch Gesundheitsw; 1971 Oct; 26(43):2020-4. PubMed ID: 4947270
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
    Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New developments in the prevention and treatment of atherosclerosis, ischemic heart disease, hyperlipidemia and other diseases].
    Samsonov MA; Isaev VA
    Vopr Pitan; 1995; (4):33-4. PubMed ID: 7483479
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of dyslipidemia].
    Cybulska B
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():11-2. PubMed ID: 12621774
    [No Abstract]   [Full Text] [Related]  

  • 8. [Atherosclerosis and arteriosclerosis of the small vessels in chronic renal insufficiency and after transplantation: lipid factors].
    Boizel R
    Nephrologie; 2000; 21(7):329-32. PubMed ID: 11200602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging non-statin LDL-lowering therapies for dyslipidemia and atherosclerosis.
    Shah PK
    Rev Cardiovasc Med; 2003; 4(3):136-41. PubMed ID: 12949442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lipid-lowering drug therapy on small-dense low-density lipoprotein.
    Backes JM; Gibson CA
    Ann Pharmacother; 2005 Mar; 39(3):523-6. PubMed ID: 15671087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The high risk cardiovascular patient.
    Dujovne CA
    Kans Med; 1985 Jan; 86(1):17-8, 31. PubMed ID: 3981850
    [No Abstract]   [Full Text] [Related]  

  • 12. [Micronized fenofibrate and LDL-cholesterol subfractions].
    Soska V
    Vnitr Lek; 1999 Jul; 45(7):441-3. PubMed ID: 11045166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of hyperlipidemia. Recommendations of the European Arteriosclerosis Society].
    Med Monatsschr Pharm; 1988 Mar; 11(3):117-9. PubMed ID: 3287113
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dyslipoproteinemias: treatment with lipid regulating drugs].
    Schwandt P
    Fortschr Med; 1990 Feb; 108(6):97-9. PubMed ID: 2323709
    [No Abstract]   [Full Text] [Related]  

  • 15. Managing dyslipidaemia: current concepts.
    Schachter M
    Practitioner; 2002 Jul; 246(1636):496-9. PubMed ID: 12132267
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug therapy of dyslipidemias].
    Fonda M; Cattin L; Guarnieri G
    Recenti Prog Med; 2000; 91(7-8):375-8. PubMed ID: 10932924
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of L-DOPA on the development of experimental hyperlipidemia and atherosclerosis].
    Mosina IV; Ryzhenkov VE
    Biull Eksp Biol Med; 1981 Mar; 91(3):270-1. PubMed ID: 7248493
    [No Abstract]   [Full Text] [Related]  

  • 18. A vote of no confidence in the precision of the estimated cost-effectiveness of lipid lowering.
    Wilcock M
    Br J Gen Pract; 2000 Nov; 50(460):917-8. PubMed ID: 11141882
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug treatment of dyslipidemias: practical guidelines for the primary care physician.
    Bays HE; Dujovne CA; Lansing AM
    Heart Dis Stroke; 1992; 1(6):357-65. PubMed ID: 1344132
    [No Abstract]   [Full Text] [Related]  

  • 20. FM-VP4 Forbes Medi-Tech.
    Burnett JR
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1120-5. PubMed ID: 14582458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.